Company record
A clear public starting point.
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.
Startup in Sahin’s portfolio

Generative AI to predict how each living being's health changes
Biostate AI is a Houston company that pairs low-cost RNA sequencing with AI models that link gene activity to disease and treatment response. It offers a blood test panel for multiple sclerosis.
Source: Biostate AI, HLTH
David Zhang, a former Rice University bioengineering professor, is CEO, and Ashwin Gopinath is CTO. The two co-founded the company.
Source: HLTH
Biostate AI raised a $12 million Series A led by Accel in May 2025. That brought its total raised to more than $20 million.
Source: HLTH
As an angel investor in 231 startups across 14 categories, I look for companies with exceptional founders, large addressable markets, and clear competitive advantages. Biostate AI stood out in the Biotech space.
Company record
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.